Congratulations! Promotions and Other Changes at Omixon

28/07/2017

We are happy to announce some changes in responsibility at Omixon as the following: Marcello Scala, former Director of Sales, EMEA became the Vice President Sales Operations, EMEA & Asia. As VP Sales Operations, Marcello will focus on generating new business directly with customers and through distributors, he...

Lab Train Me Video – What’s New in Holotype HLA V.2 Protocol?

13/07/2017

Join Omixon’s Efi Melista for a detailed explanation on what’s new in our Holotype HLA V.2 Protocol. We are happy to present faster and simpler version of the original, V.1 protocol to make HLA typing by NGS faster and easier for everyone. To watch all our previous Train Me...

HLA Explore – New Genotyping Software for HLA by NGS

28/04/2017

Omixon announce the public release of HLA Explore 1.4. HLA Explore is HLA genotyping software for genetics/genomics researchers for the analysis and interpretation of any NGS data. It is high-performance, high-throughput and high-resolution multi-sample software for genotyping analysis, interpretation and reporting. The software – featured to analyse data from any...

Omixon Welcomes Afshan Ali as Sales Manager, EMEA

12/04/2017

We are happy to announce that Afshan Ali has joined the team at Omixon’s global headquarters as a Sales Manager for the EMEA (Europe, Middle East and Africa). Afshan is a highly dynamic and successful Business Development Manager with extensive experience in working with Pharma, Diagnostics and Biotechnology companies...

2017: HLA TWIN V2.1 New Release

03/03/2017

Omixon announce today a major release for HLA Twin – the world’s most accurate, high throughput HLA genotyping software. HLA Twin V2.1 will be available as RUO and a special version will be submitted to the European Notified Body for CE-IVD certification. Thanks to the beta testers of V2.1,...